AI designs new antibiotics to fight drug-resistant superbugs
BBC - 15-Aug-2025MIT researchers use generative AI to create potential treatments for MRSA and gonorrhoea
Join the club for FREE to access the whole archive and other member benefits.
Professor at MIT and Co-founder of Radar Therapeutics
Jim Collins is the Termeer Professor of Medical Engineering & Science and Professor of Biological Engineering at MIT, as well as a Member of the Harvard-MIT Health Sciences & Technology Faculty. He is also the Co-founder of Radar therapeutics, along with Synlogic, Senti Biosciences, Sherlock Biosciences, Cellarity, and Phare Bio
The Collins research group works in synthetic biology and systems biology, with a particular focus on using network biology approaches to study antibiotic action, bacterial defense mechanisms, and the emergence of resistance. He has received numerous awards and honors, including a MacArthur "Genius" Award and the Dickson Prize in Medicine, and he is an elected member of all three national academies - the National Academy of Sciences, the National Academy of Engineering, and the National Academy of Medicine.
Visit website: https://be.mit.edu/directory/james-j-collins
See alsoDetails last updated 03-Jun-2024
MIT researchers use generative AI to create potential treatments for MRSA and gonorrhoea
Programmable mRNA tech promise precise & safe treatment for disease and age-related conditions